Effect of hydroxypropyl-beta-cyclodextrin on the solubility, photostability and in-vitro permeability of alkannin/shikonin enantiomers

被引:26
作者
Chen, CY
Chen, FA
Wu, AB
Hsu, HC
Kang, JJ
Cheng, HW
机构
[1] TAIPEI MED COLL,GRAD INST PHARMACEUT SCI,TAIPEI,TAIWAN
[2] CHIA NAN JR COLL PHARM,DEPT PHARMACEUT,TAINAN,TAIWAN
[3] NATL TAIWAN UNIV,COLL MED,INST TOXICOL,TAIPEI,TAIWAN
关键词
alkannin/shikonin enantiomers; hydroxypropyl-beta-cyclodextrin; solubility; photostability; permeability;
D O I
10.1016/0378-5173(96)04634-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of hydroxypropyl-beta-cyclodextrin (HPCD) on the solubility, photostability, and the in-vitro permeability of alkannin/shikonin enantiomers (A/S) was investigated. Solubility of AS increased approximately 200 fold at 50% HPCD. The phase-solubility diagram revealed the formation of a 1:1 inclusion complex of A/S-HPCD and a stability constant (k(s)) of 260.5 M(-1). Addition of HPCD significantly decreased the photochemical decomposition rate of A/S at pH 9.0. The apparent-first-order photochemical decomposition rate constants of free and complexed A/S were calculated from the Lineweaver-Burk plot to be 0.329 and 0.156 h(-1), respectively. The in-vitro permeability study showed that the release of A/S from four lest bases followed a Higuchi release model. The presence of HPCD enhanced the A/S release rate by 34 and 54 fold in cream and gel form, respectively, at one-tenth A/S concentration of the control preparation-Shiunko ointment.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 24 条
[1]   EFFECT OF CYCLODEXTRIN DERIVATIVES ON INDOMETHACIN STABILITY IN AQUEOUS-SOLUTION [J].
BACKENSFELD, T ;
MULLER, BW ;
WIESE, M ;
SEYDEL, JK .
PHARMACEUTICAL RESEARCH, 1990, 7 (05) :484-490
[2]   CYCLODEXTRINS IN THE PHARMACEUTICAL FIELD [J].
BEKERS, O ;
UIJTENDAAL, EV ;
BEIJNEN, JH ;
BULT, A ;
UNDERBERG, WJM .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (11) :1503-1549
[3]   EFFECT OF CYCLODEXTRIN COMPLEXATION ON THE CHEMICAL-STABILITY OF DOXORUBICIN AND DAUNORUBICIN IN AQUEOUS-SOLUTIONS [J].
BEKERS, O ;
BEIJNEN, JH ;
VIS, BJ ;
SUENAGA, A ;
OTAGIRI, M ;
BULT, A ;
UNDERBERG, WJM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 72 (02) :123-130
[4]   EFFECT OF VARIOUS CYCLODEXTRINS ON SOLUTION STABILITY AND DISSOLUTION RATE OF DOXORUBICIN HYDROCHLORIDE [J].
BREWSTER, ME ;
LOFTSSON, T ;
ESTES, KS ;
LIN, JL ;
FRIDRIKSDOTTIR, H ;
BODOR, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 79 (2-3) :289-299
[5]  
Chen FA, 1996, CHEM PHARM BULL, V44, P249, DOI 10.1248/cpb.44.249
[6]   PHOTOCHEMICAL DECOMPOSITION OF ALKANNIN SHIKONIN ENANTIOMERS [J].
CHENG, HW ;
CHEN, FA ;
HSU, HC ;
CHEN, CY .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 120 (02) :137-144
[7]   IMPROVEMENT OF ORAL BIOAVAILABILITY OF CARBAMAZEPINE BY INCLUSION IN 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN [J].
CHOUDHURY, S ;
NELSON, KF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 85 (1-3) :175-180
[8]   PHARMACEUTICAL USES OF CYCLODEXTRINS AND DERIVATIVES [J].
DUCHENE, D ;
WOUESSIDJEWE, D .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (17) :2487-2499
[9]  
FRIJLINK HW, 1991, EUR J PHARM BIOPHARM, V37, P178
[10]  
FRIJLINK HW, 1991, EUR J PHARM BIOPHARM, V37, P183